ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 38 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,211,648 | -17.0% | 542,439 | +4.0% | 0.00% | – |
| Q2 2023 | $3,868,647 | +76.1% | 521,381 | +124.3% | 0.00% | – |
| Q1 2023 | $2,196,482 | +88934.5% | 232,432 | +0.3% | 0.00% | – |
| Q4 2022 | $2,467 | -99.8% | 231,686 | +8.2% | 0.00% | – |
| Q3 2022 | $1,580,000 | +90.8% | 214,166 | +24.4% | 0.00% | – |
| Q2 2022 | $828,000 | -3.0% | 172,217 | +3.0% | 0.00% | – |
| Q1 2022 | $854,000 | -14.9% | 167,172 | 0.0% | 0.00% | – |
| Q4 2021 | $1,004,000 | -32.2% | 167,172 | 0.0% | 0.00% | – |
| Q3 2021 | $1,481,000 | +22.7% | 167,172 | +9.5% | 0.00% | – |
| Q2 2021 | $1,207,000 | +58.8% | 152,678 | +53.0% | 0.00% | – |
| Q1 2021 | $760,000 | -2.3% | 99,806 | 0.0% | 0.00% | – |
| Q4 2020 | $778,000 | -19.5% | 99,806 | 0.0% | 0.00% | – |
| Q3 2020 | $967,000 | – | 99,806 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sentinus, LLC | 149,050 | $1,408,523 | 0.47% |
| Intrepid Financial Planning Group LLC | 19,000 | $179,550 | 0.09% |
| PERRITT CAPITAL MANAGEMENT INC | 12,000 | $113,400 | 0.06% |
| Interchange Capital Partners, LLC | 11,413 | $107,853 | 0.06% |
| Virtu Financial LLC | 21,650 | $205 | 0.02% |
| CREATIVE FINANCIAL DESIGNS INC /ADV | 15,000 | $141,750 | 0.02% |
| J. Goldman & Co LP | 42,228 | $399,055 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 63,966 | $604,479 | 0.02% |
| KENNEDY CAPITAL MANAGEMENT LLC | 46,311 | $437,639 | 0.01% |
| 683 Capital Management, LLC | 16,000 | $151,200 | 0.01% |